Deciphering the epigenetic network in colorectal cancer
- PMID: 22951929
- DOI: 10.1002/path.4094
Deciphering the epigenetic network in colorectal cancer
Abstract
The sequential accumulation of genetic alterations has been classically considered responsible for the origin and subsequent progression of colorectal cancer, although recent cumulative data provide strong evidence of the significance of epigenetic changes in the development of this multi-step malignancy. Among the epigenetic alterations, miRNAs deregulation has emerged as an exciting and promising field in cancer research. In a recent issue of the Journal of Pathology, Wang and colleagues identify miR-149 as being silenced by methylation in colorectal cancer. The authors also identified Sp1 as a target of miR-149. These intriguing observations have important biological prognostic and therapeutic implications.
Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Comment on
-
SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.J Pathol. 2013 Jan;229(1):12-24. doi: 10.1002/path.4078. J Pathol. 2013. PMID: 22821729
Similar articles
-
SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.J Pathol. 2013 Jan;229(1):12-24. doi: 10.1002/path.4078. J Pathol. 2013. PMID: 22821729
-
Epigenetic regulation of microRNA expression in colorectal cancer.Int J Cancer. 2009 Dec 1;125(11):2737-43. doi: 10.1002/ijc.24638. Int J Cancer. 2009. PMID: 19521961
-
MicroRNA-22 suppresses the growth, migration and invasion of colorectal cancer cells through a Sp1 negative feedback loop.Oncotarget. 2017 May 30;8(22):36266-36278. doi: 10.18632/oncotarget.16742. Oncotarget. 2017. PMID: 28422727 Free PMC article.
-
MicroRNA Methylation in Colorectal Cancer.Adv Exp Med Biol. 2016;937:109-22. doi: 10.1007/978-3-319-42059-2_6. Adv Exp Med Biol. 2016. PMID: 27573897 Review.
-
Epigenetic alterations as cancer diagnostic, prognostic, and predictive biomarkers.Adv Genet. 2010;71:125-76. doi: 10.1016/B978-0-12-380864-6.00005-5. Adv Genet. 2010. PMID: 20933128 Review.
Cited by
-
The downregulation of NCXs is positively correlated with the prognosis of stage II-IV colon cancer.World J Surg Oncol. 2021 Jun 14;19(1):177. doi: 10.1186/s12957-021-02284-5. World J Surg Oncol. 2021. PMID: 34127021 Free PMC article.
-
CaMKII plays a part in the chondrogenesis of bone marrow-derived mesenchymal stem cells.Int J Clin Exp Pathol. 2015 May 1;8(5):5981-7. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26191331 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical